Quidel® is committed to enhancing health and well-being through innovative diagnostic solutions. Quidel assays use lateral-flow, direct fluorescent antibody, molecular and other technologies to improve patient outcomes and give economic benefits to healthcare providers. Leading brands - QuickVue®, Solana®, Sofia®, Triage®, Virena®, AmpliVue®, Lyra®, Thyretain®, InflammaDry®, AdenoPlus®, MicroVue™, and D3® Direct Detection™, aid in detection and diagnosis of critical diseases and conditions.